China awards generics contracts to lowest bidders
26-09-2019
Gilead challenges US govt patents on HIV drug Truvada
22-08-2019
Gilead claims US government PrEP patents are invalid
20-05-2019
Mark Van Scyoc / Shutterstock.com
A US congressman and senator have asked the country’s audit institution, the Government Accountability Office (GAO) to review the management of government-owned IP in the health sector.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Gilead Sciences, Government Accountability Office,Department of Health and Human Services, patent infringement, HIV
